Science Explorer Back to mapMap
Discussion
Company · Salt Lake City · United States

Carterra (United States)

carterra-bio.comROR OpenAlex
Research works
53
▼ 57% vs 2018-21
Citations
1.5k
28.1 per fractional work
Top-10% rate
10.1%
all institutions 10.0%
Open access
47%
world 40%
International
18%
world 18%
Carterra (United States)

Not ranked overall: Carterra (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Carterra (United States) work in?

In all years, 44% of research at Carterra (United States) is in Life Sciences, 33% in Health Sciences. Its largest fields are Medicine (31%), Biochemistry, Genetics and Molecular Biology (27%), Engineering (14%). It does 2.4× the world's share of Life Sciences.

Life Sciences: 23 fractional works · 44.0% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 26.5% of its workMolecular Biology: 12 fractional works · 22.8% of its workGenetics: 1 fractional works · 1.2% of its workBiochemistry: 0 fractional works · 0.6% of its workMolecular Medicine: 0 fractional works · 0.5% of its workBiotechnology: 0 fractional works · 0.5% of its workCell Biology: 0 fractional works · 0.4% of its workBiophysics: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 4 fractional works · 7.0% of its workPlant Science: 3 fractional works · 5.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.5% of its workAgronomy and Crop Science: 0 fractional works · 0.5% of its workAnimal Science and Zoology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workImmunology and Microbiology: 3 fractional works · 5.5% of its workImmunology: 2 fractional works · 4.6% of its workVirology: 0 fractional works · 0.5% of its workMicrobiology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.7% of its workPharmaceutical Science: 2 fractional works · 3.7% of its workNeuroscience: 1 fractional works · 1.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.2% of its workHealth Sciences: 17 fractional works · 33.0% of its workMedicine: 16 fractional works · 31.0% of its workRadiology, Nuclear Medicine and Imaging: 6 fractional works · 11.3% of its workInfectious Diseases: 1 fractional works · 2.8% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.7% of its workEpidemiology: 1 fractional works · 2.6% of its workOncology: 1 fractional works · 2.0% of its workEmergency Medicine: 1 fractional works · 1.3% of its workNeurology: 0 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.6% of its workFamily Practice: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.4% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workInternal Medicine: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workPhysiology: 0 fractional works · 0.2% of its workReproductive Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 1.4% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workEmergency Medical Services: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.6% of its workPeriodontics: 0 fractional works · 0.6% of its workNursing: 0 fractional works · 0.0% of its workPhysical Sciences: 11 fractional works · 21.6% of its workEngineering: 8 fractional works · 14.4% of its workBiomedical Engineering: 6 fractional works · 11.1% of its workElectrical and Electronic Engineering: 0 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.6% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.6% of its workMechanics of Materials: 0 fractional works · 0.5% of its workAutomotive Engineering: 0 fractional works · 0.4% of its workComputational Mechanics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 1 fractional works · 2.3% of its workAtmospheric Science: 1 fractional works · 1.1% of its workEarth-Surface Processes: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 2.2% of its workEcology: 1 fractional works · 1.0% of its workEnvironmental Chemistry: 0 fractional works · 0.5% of its workGlobal and Planetary Change: 0 fractional works · 0.2% of its workPollution: 0 fractional works · 0.2% of its workWater Science and Technology: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.3% of its workSurfaces, Coatings and Films: 0 fractional works · 0.6% of its workBiomaterials: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.4% of its workCondensed Matter Physics: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 1.4% of its workArts and Humanities: 0 fractional works · 0.9% of its workMuseology: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.2% of its workSocial Psychology: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.2% of its workALL ITS WORKCarterra (UnitedStates)53fractional works, all years
Life Sciences44%Physical Sciences22%Health Sciences33%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1426.5%
    2. Agricultural and Biological Sciences47.0%
    3. Immunology and Microbiology35.5%
    4. Pharmacology, Toxicology and Pharmaceutics23.7%
    5. Neuroscience11.3%
    1. Medicine1631.0%
    2. Health Professions11.4%
    3. Dentistry00.6%
    4. Nursing00.0%
    1. Engineering814.4%
    2. Earth and Planetary Sciences12.3%
    3. Environmental Science12.2%
    4. Materials Science11.3%
    5. Chemistry11.1%
    6. Physics and Astronomy00.4%
    7. Computer Science00.0%
    1. Arts and Humanities00.9%
    2. Psychology00.2%
    3. Social Sciences00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.57× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 7.25× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 3.30× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.85× its world share, 0 worksChemistryComputer Science: 0.05× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 4.08× its world share, 0 worksEarth and Planetary …Engineering: 0.49× its world share, 0 worksEngineeringMaterials Science: 0.42× its world share, 0 worksMaterials ScienceMedicine: 2.18× its world share, 2 worksMedicinePsychology: 0.32× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.2×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology7.25×0 works
  2. Biochemistry, Genetics and Molecular Biology5.57×2 works
  3. Earth and Planetary Sciences4.08×0 works
  4. Pharmacology, Toxicology and Pharmaceutics3.30×0 works
  5. Medicine2.18×2 works
  6. Chemistry1.85×0 works
  7. Engineering0.49×0 works
  8. Materials Science0.42×0 works
  9. Psychology0.32×0 works
  10. Agricultural and Biological Sciences0.12×0 works
  11. Computer Science0.05×0 works

Who are the top researchers at Carterra (United States)?

Ranked on the quality score, Daniel Bedinger, Judicaël Parisot and Adam Cohen Miles lead among researchers whose main affiliation is Carterra (United States).

  1. 1 Daniel Bedinger United States · #603,752 worldwide 1.5k citations · 39 works
  2. 2 Judicaël Parisot United States · #3,007,085 worldwide 950 citations · 19 works
  3. 3 Adam Cohen Miles United States · #3,277,476 worldwide 749 citations · 26 works
  4. 4 Noah T. Ditto United States · #4,017,384 worldwide 323 citations · 17 works
All ranked researchers at Carterra (United States)

What are the most cited papers from Carterra (United States)?

The most cited paper from Carterra (United States) is "Therapeutic strategies to combat antibiotic resistance" (Benjamin D. Brooks, Amanda E. Brooks, 2014), with 367 citations. Next come "Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study" (343) and "A critical comparison of protein microarray fabrication technologies" (180).

Most cited papers
#PaperReleasedCitations
1 Therapeutic strategies to combat antibiotic resistance Benjamin D. Brooks, Amanda E. Brooks · Advanced Drug Delivery Reviews Review 28 Oct 2014 367
2 Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study Kathryn M. Hastie et al. · Science Open access 23 Sep 2021 343
3 A critical comparison of protein microarray fabrication technologies Valentin Romanov, S. Nikki Davidoff, Adam Cohen Miles et al. · The Analyst 2014 180
4 High-Throughput Epitope Binning Assays on Label-Free Array-Based Biosensors Can Yield Exquisite Epitope Discrimination That Facilitates the Selection of Monoclonal Antibodies with Functional Activity Yasmina Noubia Abdiche, Adam Cohen Miles, Josh Eckman et al. · PLoS ONE Open access 20 Mar 2014 110
5 Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine Anna Z. Wec, Denise Haslwanter, Yasmina Noubia Abdiche et al. · Proceedings of the National Academy of Sciences Open access 9 Mar 2020 105
All 91 most cited papers, with filters and sorting

Which keywords describe research at Carterra (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Cell Culture, High-Throughput Analysis and Protein Microarrays.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycosylation8▲ 69×3 topics
  2. Monoclonal Antibodies7▲ 97×3 topics
  3. Therapeutic Antibodies7▲ 100×2 topics
  4. Antibody Engineering6▲ 106×1 topic
  5. Fc Receptors6▲ 106×1 topic
  6. Cell Culture3▲ 48×3 topics
  7. High-Throughput Analysis3▲ 109×1 topic
  8. Protein Microarrays3▲ 252×1 topic
  9. Tissue Engineering2▲ 8.6×6 topics
  10. Regenerative Medicine2▲ 19×3 topics
  11. Biopharmaceuticals2▲ 56×3 topics
  12. Hydrogels2▲ 28×2 topics
  13. Microfluidic Devices2▲ 45×2 topics
  14. Cancer2▲ 2.5×3 topics
  15. Lab-on-a-Chip2▲ 26×3 topics
  16. Vaccine2▲ 9.0×6 topics
  17. Bioinks2▲ 75×1 topic
  18. Bioprinting2▲ 75×1 topic
  19. Drug Delivery2▲ 7.0×6 topics
  20. Immune System2▲ 10×2 topics
  21. Immunogenicity2▲ 65×2 topics
  22. Glycans2▲ 38×1 topic
  23. Mucins2▲ 38×1 topic
  24. Nanoscale Patterning2▲ 46×2 topics
  25. Nanolithography2▲ 153×1 topic
  26. SARS-CoV-22▲ 19×4 topics
  27. Soft Lithography2▲ 153×1 topic
  28. Gene Expression1▲ 4.3×4 topics
  29. Recombinant Proteins1▲ 50×2 topics
  30. Microfluidics1▲ 28×2 topics
  31. Chitosan1▲ 41×1 topic
  32. Mucosal1▲ 81×1 topic
  33. Protein Aggregation1▲ 28×1 topic
  34. Reactive Oxygen Species1▲ 4.7×3 topics
  35. Stability1▲ 11×1 topic
  36. ACE2 Receptor1▲ 18×3 topics
  37. Immunity1▲ 6.0×2 topics
  38. Viral Transmission1▲ 21×2 topics
  39. Coronavirus1▲ 16×2 topics
  40. Genetic Regulation1▲ 10×2 topics

Which research topics does Carterra (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Protein purification and stability and SARS-CoV-2 and COVID-19 Research.

Monoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksGlycosylation and Glycop…0Glycosylation and Glycoproteins Research: 0 fractional worksProtein purification and…0Protein purification and stability: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksGeology and Paleoclimatology Research: 0 fractional worksAdvanced Biosensing Techniques and Applications: 0 fractional worksSynthesis and Biological Evaluation: 0 fractional worksBacillus and Francisella bacterial research: 0 fractional worksCell Adhesion Molecules Research: 0 fractional works
Radiology, Nuclear Medicine and ImagingMolecular BiologyInfectious DiseasesImmunology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  3. 3 Protein purification and stability Molecular Biology 0 works
  4. 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Geology and Paleoclimatology Research Atmospheric Science 0 works
  7. 7 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
  8. 8 Synthesis and Biological Evaluation Organic Chemistry 0 works
  9. 9 Bacillus and Francisella bacterial research Molecular Biology 0 works
  10. 10 Cell Adhesion Molecules Research Immunology and Allergy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.3%not open52.7%

World: 40% of research is openly available.

with international co-authors17.8%domestic only82.2%

World: 18% is written across borders.

How has Carterra (United States)'s research output changed?

Output in 2022-2025 was 57% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Carterra (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.00020%0.00040%Carterra (United States)0.000037% in 20251990200020102020

Fractional works of Carterra (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Carterra (United States). Posts are plain text and can be reported.